After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Zai Lab Limited ADR is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Zai Lab Limited ADR is $3.42B. A total of 0.92 million shares were traded on the day, compared to an average of 755.61K shares.
In the most recent transaction, Smiley Joshua L sold 6,641 shares of ZLAB for 36.24 per share on Aug 18 ’25. After the transaction, the insider now owns 76,604 company shares. In a previous transaction on Aug 18 ’25, Edmondson Frazor Titus III sold 1,883 shares at 36.24 per share. ZLAB shares that Chief Legal Officer owns now total 42,065.
Among the insiders who sold shares, Chen Yajing disposed of 1,438 shares on Aug 15 ’25 at a per-share price of $35.42. This resulted in the Chief Financial Officer holding 16,720 shares of ZLAB after the transaction. In another insider transaction, Edmondson Frazor Titus III bought 1,883 shares at $36.24 per share on Aug 18 ’25.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, ZLAB has a high of $44.34 and a low of $19.16.
As of this writing, ZLAB has an earnings estimate of -$0.26 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of -$0.12 per share and a lower estimate of -$0.38. The company reported an EPS of -$0.42 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ZLAB’s latest balance sheet shows that the firm has $1.41B in Cash & Short Term Investments as of fiscal 2021. There were $15.54M in debt and $192.90M in liabilities at the time. Its Book Value Per Share was $7.20, while its Total Shareholder’s Equity was $1.38B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ZLAB is Buy with a score of 4.56.
